Detection of trastuzumab efficacy using 1H MRI ex vivo of breast cancer cells

Author:

Bartusik Dorota,Tomanek Boguslaw

Publisher

Springer Science and Business Media LLC

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics

Reference18 articles.

1. Artemov D, Mori N, Ravi R, Bhujwalla ZM (2003) Magnetic resonance molecular imaging of the HER-2/neu receptor. Cancer Res 63:2723–2727

2. Bartusik D, Tomanek B, Siluk D, Kaliszan R, Fallone G (2009) The application of 19F magnetic resonance ex vivo imaging of three-dimensional cultured breast cancer cells to study the effect of δ-tocopherol. Anal Biochem 387:315–317

3. Bartusik D, Tomanek B, Lattová E, Perreault H, Fallone G (2010) Ex vivo assays of CEM cells cultured and treated in the three dimensional cultures. Biomed Pharmacother 64(6):390–395

4. Baselga J, Norton L, Albanell J, Kim YM, Mendelsohn J (1998) Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts. Cancer Res 58:2825–2831

5. Buchler P, Reber H, Buchler M, Roth M, Buchler M, Friess H, Isacoff W, Hines O (2001) Therapy for pancreatic cancer with a recombinant humanized anti-HER-2 antibody. J Gastrointest Surg 5(2):139–146

Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Evaluation of MR relaxation times following trastuzumab treatment of breast cancer cells in a 3D bioreactor;Acta Poloniae Pharmaceutica - Drug Research;2020-02-29

2. Trastuzumab drug delivery systems for magnetic resonance imaging detection;Design of Nanostructures for Theranostics Applications;2018

3. Current approaches in breast cancer targeting pharmaceuticals;Design of Nanostructures for Theranostics Applications;2018

4. Differential of live and dead cells by magnetic resonance imaging;Medicinal Chemistry Research;2017-06-01

5. A review of new approaches in Her-2 targeting and 1H MRI application;Medicinal Chemistry Research;2014-08-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3